← Back to all trials
Completed
NCT07935213
Seroprevalence and Risk Factors of H. Pylori Infection in Korea in 2023: Nationwide Multicenter Prospective Study
Conditions: HELICOBACTER PYLORI INFECTIONS, Colon Adenomas
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: Yes
Enrollment: 19680
Sponsor: Seoul National University Bundang Hospital
Location: Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do
Summary
Helicobacter pylori Infection in South Korea: Seroprevalence, Risk Factors, and Association with Colorectal Adenoma
Eligibility Criteria
Inclusion Criteria:
* Individuals undergoing routine health screening at 10 healthcare centers in South Korea between July 2023 and December 2024. The study included participants who underwent Helicobacter pylori serologic testing and gastrointestinal endoscopic examinations.
Exclusion Criteria:
* Individuals without colonoscopy or esophagogastroduodenoscopy records.
* History of colectomy.
* Inflammatory bowel disease.
* Gastric cancer or a history of gastrectomy for gastric cancer.
Source: ClinicalTrials.gov (NCT07935213). StuddyBuddy aggregates publicly available trial information.